Moreover, B cells in TLSs can function as antigen-presenting cells; they highly express the co-stimulatory molecules CD86 and CD80 and facilitate tumor antigen-specific T-cell responses, including CD8+ TIL and CD4+ TIL responses (33). Here, CD86 is linked to neoplasm.